Triple-negative breast cancer (TNBC) is a collective term used to describe breast cancers that do not express the estrogen receptor (ER) or the progesterone receptor (PR) and either do not express or do not overexpress the human epidermal growth factor receptor type 2 (HER 2). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.